Medical Director MRD Oncology Clinical Development

Labcorp; Durham (NC); Sur place; USD 320 000 - 340 000; Plein temps

Résumé du poste

Labcorp Oncology seeks a Medical Director, Clinical Development – MRD Portfolio, to lead strategic medical direction for MRD testing across solid tumors. You will shape evidence generation, clinical validity, and adoption while collaborating with R&D, market access, and regulatory affairs to advance precision oncology.

The role requires board-certified medical oncology expertise, 5+ years in clinical development and 8+ years in clinical studies, with travel up to 30%.

Qualifications

• MD or DO degree from an accredited medical school.
• Board certification in Medical Oncology.
• 5+ years of post-fellowship clinical experience treating patients with solid tumors.
• 3+ years of oncology clinical development, clinical research, or evidence-generation experience.
• 8+ years designing, leading, or supporting prospective and/or retrospective clinical studies.

Responsabilités

• Lead clinical development for Labcorp Oncology's MRD portfolio across solid tumors.
• Define clinical evidence requirements and validation strategies for MRD/ctDNA technologies.
• Guide evidence-generation programs to establish clinical validity, utility, and health economics value.
• Partner with cross-functional teams to align portfolio strategy with reimbursement and adoption goals.
• Mentor colleagues and lead external scientific collaborations to advance MRD testing.

Connaissances

Medical oncology

Clinical development

Evidence generation

Strategic leadership

Formation

MD/DO degree

Board certification in Medical Oncology

Description du poste

Labcorp Oncology seeks a Medical Director, Clinical Development – MRD Portfolio, to lead strategic medical direction for MRD testing across solid tumors. You will shape evidence generation, clinical validity, and adoption while collaborating with R&D, market access, and regulatory affairs to advance precision oncology.

The role requires board-certified medical oncology expertise, 5+ years in clinical development and 8+ years in clinical studies, with travel up to 30%.